Correlativity study between expression of DNA double-strand break repair protein and radiosensitivity of tumor cells

Abstract

DNA double-strand break (DSB) is generally regarded as the most lethal of all DNA lesions after radiation. Ku80, DNA-PK catalytic subunit (DNA-PKcs) and ataxia telangiectasia mutated (ATM) proteins are major DSB repair proteins. In this study, survival fraction at 2Gy (SF2) values of eight human tumor cell lines (including four human cervical carcinoma cell lines HeLa, SiHa, C33A, Caski, three human breast carcinoma cell lines MCF-7, MDA-MB-231, MDA-MB-453, and one human lung carcinoma cell line A549) were acquired by clone formation assay, and western blot was applied to detect the expressions of Ku80, DNA-PKcs and ATM protein. The correlativity of protein expression with SF2 value was analyzed by Pearson linear correlation analysis. We found that the expression of same protein in different cell lines and the expression of three proteins in the same cell line had a significant difference. The SF2 values were also different in eight tumor cell lines and there was a positive correlativity between the expression of DNA-PKcs and SF2 (r ＝0.723, P = 0.043), but Ku80 and ATM expression had no correlation with SF2 (P>0.05). These findings suggest that the expression level of DNA-PKcs protein can be an indicator for predicting the radiosensitivity of tumor cells.

Key words： Ku80; DNA-PK(cs)-binding protein, human; ataxia telangiectasia mutated protein; tumor cell lines; radiosensitivity

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 30672426).

References

1 Van GentD C, HoeijmakersJ H, KanaarR. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet, 2001, 2(3): 196–206

2 WeteringsE, ChenD J. DNA-dependent protein kinase in nonhomologous end joining: a lock with multiple keys?J Cell Biol, 2007, 179(2): 183–186

3 CollisS J, DeWeeseT L, JeggoP A, ParkerA R. The life and death of DNA-PK. Oncogene, 2005, 24(6): 949–961

4 LieberM R, MaY, PannickeU, SchwarzK. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol, 2003, 4(9): 712–720

5 ValerieK, PovirkL F. Regulation and mechanisms of mammalian double-strand break repair. Oncogene, 2003, 22(37): 5792–5812

6 WalkerJ R, CorpinaR A, GoldbergJ. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature, 2001, 412(6847): 607–614

7 DipR, NaegeliH. More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit. FASEB J, 2005, 19(7): 704–715

8 BudmanJ, ChuG. Processing of DNA for nonhomologous end-joining by cell-free extract. EMBO J, 2005, 24(4): 849–860

9 BoskovicJ, Rivera-CalzadaA, MamanJ D, ChacónP, WillisonK R, PearlL H, LlorcaO. Visualization of DNA-induced conformational changes in the DNA repair kinase DNA-PKcs. EMBO J, 2003, 22(21): 5875–5882

10 PawelczakK S, TurchiJ J. A mechanism for DNA-PK activation requiring unique contributions from each strand of a DNA terminus and implications for microhomology-mediated nonhomologous DNA end joining. Nucleic Acids Res, 2008, 36(12): 4022–4031

11 SakataK, SomeyaM, MatsumotoY, HareyamaM. Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med, 2007, 25(9): 433–438

12 ZhuangL, YuS Y, HuangX Y, GaoQ L, XiongH, LengY. Effect of Ku80 expression inhibition by RNA interference on proliferation of cervical carcinoma cell line HeLa. Ai Zheng, 2007, 26(3): 252–257 (in Chinese)

13 RampakakisE, Di PaolaD, Zannis-HadjopoulosM. Ku is involved in cell growth, DNA replication and G1-S transition. J Cell Sci, 2008, 121(Pt 5): 590–600

14 HsuH L, GilleyD, GalandeS A, HandeM P, AllenB, KimS H, LiG C, CampisiJ, Kohwi-ShigematsuT, ChenD J. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev, 2000, 14(22): 2807–2812

15 BaileyS M, BrennemanM A, HalbrookJ, NickoloffJ A, UllrichR L, GoodwinE H. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst), 2004, 3(3): 225–233

16 SirzenF, NilssonA, ZhivotovskyB, LewensohnR. DNA-dependent protein kinase content and activity in lung carcinoma cell lines: correlation with intrinsic radiosensitivity. Eur J Cancer, 1999, 35(1): 111–116

17 ShintaniS, MiharaM, LiC, NakaharaY, HinoS, NakashiroK, HamakawaH. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci, 2003, 94(10): 894–900

18 ZhaoH J, HosoiY, MiyachiH, IshiiK, YoshidaM, NemotoK, TakaiY, YamadaS, SuzukiN, OnoT. DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin Cancer Res, 2000, 6(3): 1073–1078

19 MorioT, KimH. Ku, Artemis, and ataxia-telangiectasia-mutated: signalling networks in DNA damage. Int J Biochem Cell Biol, 2008, 40(4): 598–603

20 BurmaS, ChenD J. Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst), 2004, 3(8-9): 909–918

21 HammarstenO, ChuG. DNA-dependent protein kinase: DNA binding and activation in the absenceβofβKu. Proc Natl Acad Sci USA, 1998, 95(2): 525–530

22 WestR B, YanevaM, LieberM R. Productive and nonproductive complexes of Ku and DNA-dependent protein kinase at DNA termini. Mol Cell Biol, 1998, 18(10): 5908–5920

23 SallesB, CalsouP, FritP, MullerC. The DNA repair complex DNA-PK, a pharmacological target in cancer chemotherapy and radiotherapy. Pathol Biol (Paris), 2006, 54(4): 185–193

24 KelleyM R, FishelM L. DNA repair proteins as molecular targets for cancer therapeutics. Anticancer Agents Med Chem, 2008, 8(4): 417–425